Skip to Content


In the US, Sunitinib (sunitinib systemic) is a member of the following drug classes: multikinase inhibitors, VEGF/VEGFR inhibitors and is used to treat Gastrointestinal Stromal Tumor, Pancreatic Cancer and Renal Cell Carcinoma.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Cytostatic agent

Angiogenesis inhibitor

Tyrosine kinase inhibitor

Chemical Names

N-[2-(Dietylamino)etyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)metyl]-2,4-dimetyl-1H-pyrrole-3-carboxamide (WHO)

5-(5-Fluor-2-oxo-1,2-dihydroindol-3-ylidenmetyl)-2,4-dimetyl-1H-pyrrol-3-carbonsäure(2-dietylaminoetyl)amid (IUPAC)

Foreign Names

  • Sunitinibum (Latin)
  • Sunitinib (German)
  • Sunitinib (French)
  • Sunitinib (Spanish)

Generic Names

  • Sunitinib (OS: BAN)
  • Sunitinib Malate (OS: USAN, BANM, JAN)
  • PHA-290940AD (IS)
  • PNU-290940AD (IS)
  • SU-010398 (IS)
  • SU-011248 (IS: L-malate salt)

Brand Names

  • Sutene
    Pfizer, South Korea
  • Sutent
    Pfizer, Egypt; Pfizer, Spain; Pfizer, Georgia; Pfizer, Lebanon; Pfizer, Norway; Pfizer, Poland; Pfizer, Tunisia; Pfizer, Turkey; Pfizer, Taiwan; Pfizer Luxembourg, Bosnia & Herzegowina; Pfizer, Argentina; Pfizer, Austria; Pfizer, Australia; Pfizer, Belgium; Pfizer, Canada; Pfizer, Switzerland; Pfizer, China; Pfizer, Czech Republic; Pfizer, Germany; Pfizer, Denmark; Pfizer, Ecuador; Pfizer, Finland; Pfizer, France; Pfizer, United Kingdom; Pfizer, Greece; Pfizer, Hong Kong; Pfizer, Croatia (Hrvatska); Pfizer, Hungary; Pfizer, Indonesia; Pfizer, Ireland; Pfizer, Israel; Pfizer, Iceland; Pfizer, Lithuania; Pfizer, Latvia; Pfizer, Malaysia; Pfizer, Netherlands; Pfizer, New Zealand; Pfizer, Philippines; Pfizer, Portugal; Pfizer, Romania; Pfizer, Serbia; Pfizer, Sweden; Pfizer, Singapore; Pfizer, Slovakia; Pfizer, Thailand; Pfizer, Vietnam; Pfizer, South Africa; Pfizer Italia, Italy; Pfizer Japan, Japan; Pfizer U.S., United States


BANBritish Approved Name
BANMBritish Approved Name (Modified)
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.